Vaccination with embryonic stem cells generates effective antitumor immunity against ovarian cancer

International Journal of Molecular Medicine

Volumn 31, Issue 1, 2013, Pages 147-153

  Zhang, Zujuan ^a   Chen, Xinhua ^a   Chang, Xiaohong ^a   Ye, Xue ^a   Li, Yi ^a   Cui, Heng ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

Antitumor immunity; Cancer vaccine; Embryonic stem cell; Immunotherapy; Ovarian cancer

Indexed keywords

CANCER VACCINE; EMBRYONIC STEM CELL VACCINE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; MYC PROTEIN; NUCLEOSIDE DIPHOSPHATE KINASE NM23; PHOSPHATE BUFFERED SALINE; PROTEIN P53; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIGEN EXPRESSION; ARTICLE; BLOOD TOXICITY; CANCER CELL CULTURE; CANCER IMMUNIZATION; CANCER INHIBITION; CANCER MODEL; CANCER SURVIVAL; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RESPONSE; DISTANT METASTASIS; DRUG EFFICACY; DRUG SAFETY; EMBRYO; EMBRYONIC STEM CELL; FEMALE; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNOGENICITY; IMMUNOHISTOCHEMISTRY; LIVER METASTASIS; LUNG METASTASIS; MOUSE; NONHUMAN; OVARY ADENOCARCINOMA; OVARY CANCER; OVARY CARCINOMA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SURVIVAL TIME; TUMOR IMMUNITY;

ANIMALS; BLOTTING, WESTERN; CANCER VACCINES; CELL DIFFERENTIATION; CELL LINE, TUMOR; EMBRYONIC STEM CELLS; FEMALE; GENES, ERBB-2; GENES, MYC; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY; LIVER; MICE; MICE, INBRED C57BL; MODELS, ANIMAL; OVARIAN NEOPLASMS; RATS; RATS, INBRED F344; TUMOR SUPPRESSOR PROTEIN P53; VACCINATION;

EID: 84873164609     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2012.1195     Document Type: Article

References (18)

1. Li Y, Zeng H, Xu RH, Liu B and Li Z: Vaccination with human pluripotent stem cells generates a broad spectrum of immunological and clinical responses against colon cancer. Stem Cells 27: 3103-3111, 2009.
2. Mocan T and Iancu C: Effective colon cancer prophylaxis in mice using embryonic stem cells and carbon nanotubes. Int J Nanomed 6: 1945-1954, 2011.
3. Roby KF, Taylor CC, Sweetwood JP, et al: Development of a syngeneic mouse model for events related to ovarian cancer. Carcinogenesis 21: 585-591, 2000.
4. Rose GS, Tocco LM, Granger GA, et al: Development and characterization of a clinically useful animal model of epithelial ovarian cancer in the Fischer 344 rat. Am J Obstet Gynecol 175: 593-599, 1996.
5. Nolz JC, Starbeck-Miller GR and Harty JT: Naive, effector and memory CD8 T-cell trafficking: parallels and distinctions. Immunotherapy 3: 1223-1233, 2011.
6. Dong W, Du J, Shen H, et al: Administration of embryonic stem cells generates effective antitumor immunity in mice with minor and heavy tumor load. Cancer Immunol Immunother 59: 1697-1705, 2010.
7. Brewer BG, Mitchell RA, Harandi A and Eaton JW: Embryonic vaccines against cancer: an early history. Exp Mol Pathol 86: 192-197, 2009.
8. Huebener N, Fest S, Hilt K, et al: Xenogeneic immunization with human tyrosine hydroxylase DNA vaccines suppresses growth of established neuroblastoma. Mol Cancer Ther 8: 2392-2401, 2009.
9. Niitsu N, Nakamine H and Okamoto M: Expression of nm23-H1 is associated with poor prognosis in peripheral T-cell lymphoma, not otherwise specified. Clin Cancer Res 17: 2893-2899, 2011.
10. Wang PH, Yi YC, Tsai HT, et al: Significant association of genetic polymorphism of human nonmetastatic clone 23 type 1 gene with an increased risk of endometrial cancer. Gynecol Oncol 119: 70-75, 2010.
11. Kedrin D, Wyckoff J, Boimel PJ, et al: ERBB1 and ERBB2 have distinct functions in tumor cell invasion and intravasation. Clin Cancer Res 15: 3733-3739, 2009.
12. Lekka E, Gritzapis AD, Perez SA, et al: Identification and characterization of a HER-2/neu epitope as a potential target for cancer immunotherapy. Cancer Immunol Immunother 59: 715-727, 2010.
13. Schade B, Rao T, Dourdin N, et al: PTEN deficiency in a luminal ErbB-2 mouse model results in dramatic acceleration of mammary tumorigenesis and metastasis. J Biol Chem 284: 19018-19026, 2009.
14. Rodriguez OC, Lai EW, Vissapragada S, et al: A reduction in Pten tumor suppressor activity promotes ErbB-2-induced mouse prostate adenocarcinoma formation through the activation of signaling cascades downstream of PDK1. Am J Pathol 174: 2051-2060, 2009.
15. Huang S, Benavente S, Armstrong EA, Li C, Wheeler DL and Harari PM: p53 modulates acquired resistance to EGFR inhibitors and radiation. Cancer Res 71: 7071-7079, 2011.
16. Sasaki Y, Negishi H, Idogawa M, et al: p53 negatively regulates the hepatoma growth factor HDGF. Cancer Res 71: 7038-7047, 2011.
17. Yasojima H, Shimomura A, Naoi Y, et al: Association between c-myc amplification and pathological complete response to neoadjuvant chemotherapy in breast cancer. Eur J Cancer 47: 1779-1788, 2011.
18. Chen Y, Xu J, Borowicz S, Collins C, Huo D and Olopade OI: c-Myc activates BRCA1 gene expression through distal promoter elements in breast cancer cells. BMC Cancer 11: 246, 2011.